间歇性PTH治疗对人类骨重塑和建模的细胞效应 - - 一个以组织形态测量为中心的范围审查
Lisbeth Koch Thomsen1, Pernille van Dijk Christiansen1, Christina Møller Andreasen1,2
1Molecular Bone Histology Lab, Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
概括
间歇性副甲状腺激素 (PTH) 治疗可促进骨质疏松症和副甲状腺功能低下症患者的骨细胞活性. 骨形成主要是由骨质细胞启动的过程引起的,而不是模型,突出显示新的治疗途径.
科学领域:
- 骨生物学 骨生物学 骨生物学
- 内分泌学 在内分泌学.
- 骨质疏松症研究 骨质疏松症研究
背景情况:
- 间歇性副甲状腺激素 (PTH) 疗法是长期治疗骨质疏松症和副甲状腺功能障碍症的方法.
- 它在骨组织中的精确细胞机制仍然不完全理解.
研究的目的:
- 审查和重新解释组织形态测量和骨周转标志物研究.
- 为了阐明间歇性PTH治疗对骨的细胞效应.
- 识别当前理解中的知识差距.
主要方法:
- 使用组织形态测量的研究的范围审查.
- 系统性骨周转标记物的分析.
- 重新解释关于间歇性PTH治疗效应的现有数据.
主要成果:
- 间歇性PTH在前六个月内增加了骨质细胞和骨质细胞的活动.
- 在骨质疏松症中,骨质细胞活性最初增加,随后骨质细胞活化增加,随后恢复到基线骨质形成.
- 在缺甲状腺症中,PTH治疗在较长时间内增加并使骨形成正常化,对骨质细胞的行为数据有限.
结论:
- 由PTH诱导的骨形成主要是由骨质细胞启动的重塑 (RBF,oRBF) 而不是模型 (MBF) 驱动的.
- 增加骨质形成可能涉及以前被捕的侵蚀表面的再生.
- 需要对PTH的影响进行进一步的研究,特别是关于以前的抗复苏治疗.
更多相关视频
相关概念视频
Bone Remodeling
40.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
Hormones and Bone Tissue
3.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K


